Source: Eur Respir J, 51 (5) 1800190; 10.1183/13993003.00190-2018
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Ramón Rami-Porta, Sergi Call, Christophe Dooms, Carme Obiols, Marcelo Sánchez, William D. Travis, Ivan Vollmer. Lung cancer staging: a concise update. Eur Respir J, 51 (5) 1800190; 10.1183/13993003.00190-2018

Member's Comments

No comment yet.

Related content which might interest you: Lung cancer: screening and staging Source: Eur Respir Monogr 2015; 70: 47-59 Year: 2015 Lung cancer screening: the critical review Source: International Congress 2015 – Lung cancer screening: how to implement a comprehensive preventive approach Year: 2015 Lung cancer: staging with respect to the new 8th TNM-classification Source: International Congress 2018 – Imaging Grand Round Year: 2018 Mediastinal staging in lung cancer: A rational approach Source: Annual Congress 2010 - Staging of lung cancer Year: 2010 Combined endobronchial and esophageal endosonography for mediastinal staging in lung cancer: Systematic review and meta-analysis Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Does IASLC/ATS/ERS classification of lung adenocarcinoma impacts prognosis? Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 EBUS-TBNA for nodal restaging and relapse in lung cancer Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Lung disease induced by newer therapies for lung cancer: an update Source: Annual Congress 2006 - Drug-induced lung injury – new aspects Year: 2006 Should all lung cancer patients requiring pathological nodal staging undergo PET-CT first? Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Improving NLST criteria for lung cancer screening Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Lung cancer screening - where we are and how to implement it Source: International Congress 2018 – ME5 Lung cancer screening Year: 2018 Comparing performance and cost of EBUS-TBNA versus other methods for diagnosis and staging of non-small cell lung cancer (NSCLC) Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Treatment and survival in patients with pulmonary carcinoid tumours; an updated analysis from the UK national lung cancer audit Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015 Diagnosing lung cancer: Choosing the best for your patient Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Computed tomographic screening for lung cancer: individualising the benefit of the screening Source: Eur Respir J 2007; 30: 843-847 Year: 2007